To examine the anti-tumor efficacy of DC1 vaccine in a HER2+ breast tumor model, we utilized the TUBO cell line which was derived from a spontaneous mammary tumor in Balb/c mice transgenic for the rat Her-2/neu gene (BALB-neuT). This evidence concerns the gene ERBB2 and breast neoplasm.